Clarke A. Low, MD
Disclosures: Nothing to disclose - 06/17/2021

Clarke Low, MD


PERSONAL INFORMATION                                                                                                                                                                       

Business address:                            Intermountain Medical Center

5171 S Cottonwood Dr

                                                        Building 1, Suite 610             

                                                        Murray, UT  84107

Email address:                                          [email protected]

Mobile phone:                                          310-488-9596

Home address:                                          1876 London Plane Rd

                                                        Holladay, UT  84124

Citizenship:                                          U.S.


CURRENT APPOINTMENT                                                                                                                                                                       

07/2018 – present                            Director, Thoracic Oncology

                                                        Intermountain Healthcare

07/2018 – present                            Hematologist/Oncologist

                                                        Intermountain Medical Center, Intermountain Healthcare


EDUCATION AND TRAINING                                                                                                                                                                       


07/2015 – 06/2018                            Fellowship, Hematology and Oncology

                                                        Divisions of Hematology and Oncology

                                                        University of Utah and Huntsman Cancer Institute, Salt Lake City, UT

07/2012 – 06/2015                            Internship and Residency

                                                        Department of Medicine

                                                        University of California Los Angeles – Ronald Reagan Medical Center, Los Angeles, CA


2008 – 2012                                          Doctorate of Medicine, Honors

                                                        Baylor College of Medicine, Houston, TX


2005-2008                                          Masters of Science, Chemical Engineering

                                                        Massachusetts Institute of Technology, Cambridge, MA


1999 – 2005                                          Bachelors of Science, Chemical Engineering, summa cum laude

                                                        Brigham Young University, Provo, UT


LICENSURE AND CERTIFICATION                                                                                                                                                         

2018 – present                                          Medical oncology, American Board of Internal Medicine

2018 – present                                          Hematology, American Board of Internal Medicine

2015 – present                                          Internal medicine, American Board of Internal Medicine

2015 – present                                          Utah Board of Physicians and Surgeons

                                                        UT 9355821-1205, Expires 01/31/2022

2015 – present                                          Drug Enforcement Agency

                                                        FL5259963, Expires 03/31/2021


PROFESSIONAL EXPERIENCE                                                                                                                                                                       


  • Medical oncology clinic (twice weekly) with focus on thoracic, head and neck malignancies, Intermountain Medical Center
  • Multi-disciplinary thoracic tumor board (weekly), Intermountain Medical Center
  • Multi-disciplinary head and neck tumor board (biweekly), Intermountain Medical Center



  • Quality improvement officer for Commission on Cancer Committee for Intermountain Medical Center
  • Member lung cancer steering committee for Intermountain Healthcare
  • Improving percentage of and timeliness of molecular testing for all advanced non-small cell lung cancer
  • Grant funded project to improve tobacco cessation referral to state quit line



03/2017 present              Fort Harrison, Montana VA Hospital

                                          Medical Officer of the Day

Provide weekend hospitalist coverage for new admissions, hospitalized and ICU patients on an occasional basis (typically once every 6 months)


01/2017 – 06/2018              Wellcon, Inc

                                          Salt Lake County Metro Jail

                                          Acute Clinic Physician

Provided 2-4 hour half-day clinics addressing internal medicine acute problems several days/month.


02/2014 – 06/2015              City of Los Angeles

                                          Medical Provider, Level 1

Provided initial and ongoing medical assessment and care in local city jails (Van Nuys, downtown LA, Watts) for newly arrested men and women with medical history or medical complaints over 12-hour shift, typically several days/month.



Clinical Trial Experience

              Principal Investigator:

                            CODEBREAK 200 (AMG 510 2019009): A Phase 3 Multicenter, Randomized, Open Label, Active controlled, Study of AMG 510 versus Docetaxel for the Treatment of previously treated Locally Advanced and unresectable or Metastatic NSCLC Subjects with Mutated KRRAS p.G12C; NCT04303780



CA209816 (Checkmate 816): Randomized, Open-Label, Phase 3 Trial of nivolumab and ipilimumab versus platinum-doublet Chemotherapy in Early Stage NSCLC; NCT02468024


TAPUR Study: The Targeted Agent and Profiling Utilization Registry (TAPUR) Study; NCT 02693535


SWOG S1415CD: A Pragmatic Trial to Evaluate a Guideline Based Colony Stimulating Factor Standing Order Intervention and to Determine the Effectiveness of Colony Stimulating Factor Use as Prophylaxis for Patients Receiving Chemotherapy with Intermediate Risk for Febrile Neutropenia; NCT02728596


ALCHEMIST Trial: Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial; NCT02194728, NCT02193282; NCT02201992



Research projects

07/2015 06/2018              Department of Medicine

                                          Division of Hematology, Division of Oncology

                                          University of Utah

                                          Fellow physician

                            Mentor: Ahmad Halwani, MD

Developed methods to extract clinical lab information from VA database. Worked on project to develop natural language processing in radiology reports to extract information. Evaluated real-world data from national VA population regarding use of cytogenetic and FISH testing in patients with chronic lymphocytic leukemia. Evaluated real-world data from national VA population describing treatment patterns in patients with metastatic castrate-resistance prostate cancer.


07/2013 – 06/2015              Department of Medicine

                                          University of California, Los Angeles

                                          Resident physician

                            Mentor: Neil Wenger, MD

Assessed whether advanced care planning documents, specifically CODE status, was successfully communicated to skilled nursing facilities when a patient is discharged from hospital. Worked with multidisciplinary team to improve documentation of CODE status, completion of POLST forms, and communication of this information to nursing facilities


07/2009 – 05/2012              Department of Radiation Oncology

                                          MD Anderson Cancer Center, Houston, TX

                                          Medical student, Baylor College of Medicine

Mentor: Anita Mahajan, MD

Explored clinical outcomes on young adults with CNS malignancies treated with craniospinal irradiation.





Low C. Wenger N, Simon W, Walling A. Improving Documentation of Code Status for Patients Discharged to Nursing Homes. Quality Improvement Seminar, UCLA Internal Medicine Grands Rounds, June 2014; Los Angeles, CA


Leung P, Low C, Walling A, Wenger N. Deficits in the Transfer of Advance Care Planning Information for Patients Discharged from Hospitals to Nursing Homes. Society of General Internal Medicine, Geriatrics/Aging/End-of-Life Session, April 2014; San Diego, CA.




Patil V, Rasmussen K, Burningham Z, Low C, Gupta S, Sauer B, Halwani A. Using natural language processing in radiology reports to extract the concept of metastatic disease in Veterans with prostate cancer. American VA Hematology Oncology Conference. 2017. Denver, CO.


Patil V, Rasmussen K, Burningham Z, Low C, Gupta S, Sauer B, Halwani A. The role of academic affiliation in the treatment of metastatic castrate-resistant prostate cancer in the Veterans Health Administration. American VA Hematology Oncology Conference. 2017. Denver, CO.


Halwani A, Burningham Z, Rasmussen K, Patil V, Low C, Meissner B, Kapustyan T, Lawrence N, Walker J, Keim H, Sauer B. Cytogenetic and fluorescence in situ hybridization testing in veterans with chronic lymphocytic leukemia. ASCO 2017; Chicago, IL.


Halwani A, Hansen J, Burningham Z, Low C, Huynh T, Sauer B. A transparent and reproducible pipeline for extracting clinical lab information from a nationwide healthcare system’s (VHA) Corporate Data Warehouse (CDW). Research Reproducibility Conference, University of Utah; November 2016; Salt Lake City, UT.


Mahajan A, Low C. Preliminary Experience with Adult Proton Craniospinal Irradiation. Society of NeuroOncology 16th Annual Scientific Meeting 2011; Orange County, CA.



Low C. Transient Oxygen Consumption Rate Measurements of Islet Tissue with the BDTM Oxygen Biosensor System. 2008. Masters Thesis, MIT, Cambridge, MA.


EDUCATIONAL ACTIVITIES                                                                                                                                                                       

Professional Associations             

2016 – present                            American Society of Clinical Oncologists

2018 – present                            Utah Medical Association


CME / Clinical Instruction Lecturer

01/2021              Invited Speaker, 2021 Intermountain Cardiothoracic Surgery Sympostim, Salt Lake City, UT

09/2019              Invited Speaker, OncLive State of the Science Summit – Lung Cancer, Salt Lake City, UT

03/2019              Invited Speaker, Society for Immunotherapy of Cancer Conference, Salt Lake City, UT

05/2018              Invited Speaker, North American Neuroendocrine Tumors Society Conference, Salt Lake City, UT


HONORS AND AWARDS                                                                                                                                                                       

2015              UCLA Olga Levin Inspiration Award given by Internal Medicine Residency program to graduating senior resident who inspires excellence in clinical, teaching, and research

2013-2015              UCLA Commendation for excellence in medical student teaching

2013-2014              UCLA Housestaff quality improvement scholarship

2012              Elected to alpha omega alpha honor society

2012              Gold humanism award

2008-2012               Merit scholarship – Baylor College of Medicine

2005-2006              DuPont Presidential Fellowship – MIT

2005              Commence speaker, College of Engineering – Brigham Young University

2005              American Institute of Chemical Engineering (AIChE) Outstanding Senior Award Salt Lake City Area

2004              Outstanding Junior Award, Chemical Engineering – Brigham Young University

2003-2005              Edwin S Hinckley Scholar – Brigham Young University